Investigation Overview
June 2, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Eleven Biotherapeutics. The investigation by a law firm concerns whether certain Eleven Biotherapeutics officers and directors brea...
You must register (for free) or login to view the entire investigation.